TUMBARELLO, MARIO
 Distribuzione geografica
Continente #
NA - Nord America 11.415
EU - Europa 4.176
AS - Asia 2.829
SA - Sud America 675
AF - Africa 86
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 19.185
Nazione #
US - Stati Uniti d'America 11.310
RU - Federazione Russa 1.365
IT - Italia 1.223
SG - Singapore 961
CN - Cina 787
BR - Brasile 580
IE - Irlanda 435
HK - Hong Kong 288
KR - Corea 280
DE - Germania 215
VN - Vietnam 199
GB - Regno Unito 185
SE - Svezia 144
FR - Francia 134
FI - Finlandia 130
IN - India 98
NL - Olanda 93
CA - Canada 60
ES - Italia 44
PL - Polonia 42
AT - Austria 38
ZA - Sudafrica 35
BD - Bangladesh 31
MX - Messico 31
AR - Argentina 30
UA - Ucraina 29
CI - Costa d'Avorio 23
CZ - Repubblica Ceca 23
EC - Ecuador 21
IQ - Iraq 21
JP - Giappone 20
TR - Turchia 20
LT - Lituania 14
AE - Emirati Arabi Uniti 13
CO - Colombia 13
ID - Indonesia 13
BE - Belgio 12
EG - Egitto 11
UZ - Uzbekistan 11
IR - Iran 10
PE - Perù 10
SA - Arabia Saudita 10
BG - Bulgaria 7
CH - Svizzera 7
CL - Cile 6
IL - Israele 6
JO - Giordania 6
VE - Venezuela 6
AZ - Azerbaigian 5
GE - Georgia 5
KE - Kenya 5
LU - Lussemburgo 5
LV - Lettonia 5
MA - Marocco 5
PK - Pakistan 5
PY - Paraguay 5
DK - Danimarca 4
HR - Croazia 4
KZ - Kazakistan 4
MY - Malesia 4
PT - Portogallo 4
AL - Albania 3
AM - Armenia 3
BH - Bahrain 3
CR - Costa Rica 3
LB - Libano 3
LK - Sri Lanka 3
NG - Nigeria 3
YE - Yemen 3
AU - Australia 2
BO - Bolivia 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GT - Guatemala 2
KG - Kirghizistan 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
NO - Norvegia 2
OM - Oman 2
PH - Filippine 2
RS - Serbia 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
KW - Kuwait 1
NR - Nauru 1
PA - Panama 1
RO - Romania 1
SN - Senegal 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 19.181
Città #
Dallas 9.439
Singapore 606
Moscow 453
Dublin 419
Hefei 327
Hong Kong 285
Seoul 279
Santa Clara 276
Ashburn 251
Milan 248
Siena 141
Florence 139
Beijing 138
Chandler 116
Los Angeles 88
Southend 87
Munich 86
Ho Chi Minh City 82
Helsinki 67
New York 66
Rome 60
São Paulo 57
Bengaluru 55
Fairfield 54
Chicago 52
Nuremberg 44
Princeton 43
Buffalo 36
Hanoi 35
The Dalles 32
Brescia 30
Lappeenranta 30
Shanghai 30
Turku 29
London 24
Abidjan 23
Lauterbourg 23
Rio de Janeiro 23
Seattle 23
Warsaw 23
Redondo Beach 22
Johannesburg 21
Montreal 20
Tokyo 19
Vienna 19
Houston 18
Portsmouth 18
Woodbridge 18
Boardman 17
Brasília 17
Denver 17
Gdynia 17
Stockholm 17
Düsseldorf 16
Wilmington 16
Málaga 15
Curitiba 14
Jacksonville 14
Washington 14
Brooklyn 13
Frankfurt am Main 13
Orem 13
Toronto 13
Boston 12
Brussels 12
Paris 12
Brno 11
Council Bluffs 11
Figline Valdarno 11
Mexico City 11
Naples 11
Poplar 11
Atlanta 10
Belo Horizonte 10
Bologna 10
Chennai 10
Comun Nuovo 10
Fremont 10
Messina 10
San Diego 10
Amsterdam 9
Cairo 9
Cambridge 9
Querétaro 9
Salt Lake City 9
Tashkent 9
Ankara 8
Cape Town 8
Charlotte 8
Guangzhou 8
Haiphong 8
Hải Dương 8
Lima 8
Phoenix 8
San Francisco 8
Tehran 8
Carrara 7
Elk Grove Village 7
Manaus 7
Olomouc 7
Totale 15.044
Nome #
(1,3)-β-d-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: A randomized trial 7.186
Compassionate use of meropenem/vaborbactam for infections caused by KPC-producing Klebsiella pneumoniae: a multicentre study 604
A first update on mapping the human genetic architecture of COVID-19 539
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 459
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 328
An explainable model of host genetic interactions linked to COVID-19 severity 324
Colonizzazione e trapianto di polmone: il possibile ruolo dei colonizzanti multiresistenti sugli eventi infettivi in uno studio pilota osservazionale-retrospettivo 282
Pathogen-sugar interactions revealed by universal saturation transfer analysis 269
Mapping the human genetic architecture of COVID-19 262
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 258
Programma di vaccinazione antiMpox e screening infettivologico: opportunità di prevenzione in differenti categorie a rischio 256
Long Covid: analisi di casistica in follow-up a seguito di successive ondate epidemiche 255
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV 240
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 232
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 225
Severe COVID-19 in hospitalized carriers of single CFTR pathogenic variants 204
Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes 197
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 191
B cell response six months after SARS-CoV-2 mRNA vaccination in people living with HIV under antiretroviral therapy 185
Ultra-rare RTEL1 gene variants associate with acute severity of COVID-19 and evolution to pulmonary fibrosis as a specific long COVID disorder 167
Antigenic sin and multiple breakthrough infections drive converging evolution of COVID-19 neutralizing responses 156
Colonizzazione da batteri multiresistenti nel trapianto di polmone ed eventi infettivi: studio pilota osservazionale-retrospettivo 153
ACKNOWLEDGEMENT OF REVIEWERS 153
Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound? 148
Whole-genome sequencing reveals host factors underlying critical COVID-19 143
An Observational Study to Develop a Predictive Model for Bacterial Pneumonia Diagnosis in Severe COVID-19 Patients—C19-PNEUMOSCORE 138
Evaluation of the New NucliSENS EasyQ KPC Test for Rapid Detection of Klebsiella pneumoniae Carbapenemase Gene (blaKPC) 138
Ceftazidime-avibactam use for klebsiella pneumoniae carbapenemase-producing k. pneumoniae infections: a retrospective observational multicenter study 138
B cell analyses after SARS-CoV-2 mRNA third vaccination reveals a hybrid immunity like antibody response 136
Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine 131
Efficacy and Durability of Dolutegravir- or Darunavir-Based Regimens in ART-Naïve AIDS- or Late-Presenting HIV-Infected Patients. 131
Patient profile characteristics when choosing different Dolutegravir-based dual therapies: impact on long term efficacy and durability 130
Ceftolozane/tazobactam for treatment of severe ESBL-producing enterobacterales infections: A multicenter nationwide clinical experience (CEFTABUSE II Study) 130
Fatal inflammatory AIDS-associated PML with high CD4 counts on HAART: a new clinical entity? 129
Liver fibrosis stage predicts early treatment outcomes with peginterferon plus ribavirin in HIV/hepatitis C virus co-infected patients 123
Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants 122
Urinary tract infections caused by Gram-negative bacteria in elderly hospitalized patients: epidemiology, clinical features and outcomes in the era of antimicrobial resistance 121
Evolution of anal HPV infection and HPV-related squamous intraepithelial lesions in a cohort of PLWH: is there a benefit of HPV vaccination? 119
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine) 118
High prevalence of Hepatic Steatosis in a cohort of People Living With HIV: exploring the role of metabolic and HIV-related factors 115
PRESTIGIO RING “a 59-year-old man with multidrug resistant HIV-1 infection failing a regimen including dolutegravir, rilpivirine, atazanavir/cobicistat: successful treatment tailoring based on genotypic and phenotypic resistance tests” 114
Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey 114
Vaccinazione anti SARSCov2 in una coorte di pazienti sottoposti a trapianto di cuore o di polmone: risposta umorale a dosi booster 111
Clinical impact of ceftazidime/avibactam on the treatment of suspected or proven infections in a large cohort of patients with haematological malignancies: a multicentre observational real-world study 111
Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant 110
Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey 110
Safety and Efficacy of Outpatient Treatments for COVID-19: Real-Life Data from a Regionwide Cohort of High-Risk Patients in Tuscany, Italy (the FEDERATE Cohort) 108
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry 105
Trattamento efficace di osteomielite sternale con raccolta purulenta da Klebsiella pneumoniae multiresistente in recente trapianto di polmone 101
Third Sars-CoV-2 vaccine dose: B cell and antibody responses following heterologous and homologous vaccination strategies. 101
Prevalence, Incidence and Predictors of Anal HPV Infection and HPV-Related Squamous Intraepithelial Lesions in a Cohort of People Living with HIV 99
Successivi booster vaccinali contro SARS-CoV-2: risposta umorale in pazienti sottoposti a trapianto di cuore o di polmone 96
Successful treatment of complicated infective endocarditis due to Enterococcus faecium in a patient with substance use disorder using oritavancin as sequential maintenance therapy 96
Prevalence and correlates of Hepatic Steatosis and Metabolic-associated Fatty Liver Disease in a cohort of People Living With HIV 96
Characterisation and risk factor profiling of Pseudomonas aeruginosa urinary tract infections: pinpointing those likely to be caused by multidrug-resistant strains 96
A new call for influenza and pneumococcal vaccinations during COVID-19 pandemic in Italy: A SIP/IRS (Italian Respiratory Society) and SITA (Italian Society of Antiinfective therapy) statement 96
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 95
Meropenem-vaborbactam as intrathecal-sparing therapy for the treatment of carbapenem-resistant K. pneumoniae shunt-related ventriculitis: two case reports and review of the literature 94
Outcomes and Predictors of Mortality in Patients With KPC-Kp Infections Treated With Meropenem Vaborbactam: An Observational Multicenter Study 93
Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosis 93
Rapid Decrease in Fluoroquinolones Consumption following Implementation of a Simple Antimicrobial Stewardship Bundled Intervention in a University Hospital during the COVID-19 Pandemic 92
Persistence of spike-specific memory B cells and antibodies nine months after two doses of BNT162b2 mRNA vaccine. 91
Adjunctive immunotherapeutic agents in patients with sepsis and septic shock: a multidisciplinary consensus of 23 87
Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases: A SEIFEM group position paper 85
Polypharmacy, anticholinergic burden and drug-drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registry 83
The Uprise of Human Leishmaniasis in Tuscany, Central Italy: Clinical and Epidemiological Data from a Multicenter Study 83
Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use 78
Risk factors for candidemia after open heart surgery: Results from a multicenter case-control study 77
Predictors of mortality in solid organ transplant recipients with bloodstream infections due to carbapenemase-producing Enterobacterales: The impact of cytomegalovirus disease and lymphopenia 76
Primary Cutaneous Cryptococcosis in an Immunocompetent Patient: Diagnostic Workflow and Choice of Treatment 71
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 71
Diagnosis and management of infections caused by multidrug-resistant bacteria: guideline endorsed by the Italian Society of Infection and Tropical Diseases (SIMIT), the Italian Society of Anti-Infective Therapy (SITA), the Italian Group for Antimicrobial Stewardship (GISA), the Italian Association of Clinical Microbiologists (AMCLI) and the Italian Society of Microbiology (SIM) 70
Meropenem/vaborbactam: a next generation β-lactam β-lactamase inhibitor combination 68
Molecular mechanisms, epidemiology, and clinical importance of β-lactam resistance in enterobacteriaceae 68
XDR-Pseudomonas aeruginosa Outside the ICU: Is There Still Place for Colistin? 66
Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae 66
Evaluating cefiderocol in the treatment of multidrug-resistant gram-negative bacilli: A review of the emerging data 66
Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study 65
Use of colistin in adult patients: A cross-sectional study 64
Factors associated with inadequate intravenous colistin dosages: Post hoc analysis of a multicenter, cross-sectional study 63
Epidemiology, aetiology and treatment of skin and soft tissue infections: final report of a prospective multicentre national registry 60
Identification of two anti-Candida antibodies associated with the survival of patients with candidemia 58
SARS CoV 2 infection in chronic myelogenous leukemia: Severe hematological presentation 58
Posterior Reversible Encephalopathy Syndrome After Intramuscular Oxygen-Ozone Therapy 56
Clinical outcomes in elderly patients with infections caused by NDM-producing Klebsiella pneumoniae: results from a real-life retrospective single center study in an endemic area 55
Multicenter Observational Retrospective Study on Febrile Events in Patients with Acute Myeloid Leukemia Treated with Cpx-351 in "Real-Life": The SEIFEM Experience 55
How to tailor recommendations on the treatment of multi-drug resistant Gram-negative infections at country level integrating antibiotic stewardship principles within the GRADE-ADOLOPMENT framework 55
Predictors for Prolonged Hospital Stay Solely to Complete Intravenous Antifungal Treatment in Patients with Candidemia: Results from the ECMM Candida III Multinational European Observational Cohort Study 54
SARS-CoV-2 infection in a highly experienced person living with HIV 54
New Drugs for the Treatment of Pseudomonas aeruginosa Infections with Limited Treatment Options: A Narrative Review 53
Invasive Respiratory Fungal Infections in COVID-19 Critically Ill Patients 46
Low rate of infectious mortality omitting fluoroquinolone prophylaxis in high-risk hematological patients, a single centre experience 27
Totale 19.495
Categoria #
all - tutte 49.598
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.598


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202135 0 0 0 0 0 7 1 10 5 4 5 3
2021/2022310 15 9 2 8 4 3 31 57 13 26 53 89
2022/2023773 38 82 91 65 36 109 98 85 56 34 59 20
2023/20241.021 48 34 101 65 52 197 292 53 10 40 43 86
2024/20253.486 149 98 250 144 452 204 337 203 244 206 344 855
2025/202613.730 568 3.313 7.173 1.228 1.372 76 0 0 0 0 0 0
Totale 19.495